Phase 3 Trial of Secukinumab in Polymyalgia Rheumatica - John H. Stone; Frank Buttgereit; Alain Saraux; Wolfgang A. Schmidt; Christian Dejaco; Robert Spiera; Bhaskar Dasgupta; Edit Drescher; Andrew Jordan; Libor Novosad; Daiki Nakagomi; Yoshinobu Koyama; et al. (New England Journal of Medicine, 2026)